保誠(02378.HK)任命Guido Fürer為非執行董事
格隆匯7月1日丨保誠(02378.HK)宣佈,任命 Guido Fürer 博士為非執行董事。
葉約德將於 2025 年 10 月 31 日任滿六年後退出董事會。
保誠主席 Shriti Vadera 表示:「Fürer 博士知識廣博,涵蓋資產管理、保險及資產負債管理等領域,這一切皆源於他傑出的管理生涯和環球的董事會歷練。我很高興歡迎他加入董事會。」
「同時,葉女士在董事會服務近六年,今年任滿後將會榮休,我們對她即將卸任感到惋惜。藉此機會,我謹代表董事會感謝葉女士在協助董事會於集團經歷重大變革期間指導和監督方面所作出的寶貴貢獻。」
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.